Meet Your Care Team: Karlee Carlin, PA-C
In early May, we welcomed Karlee to our team as a study sub-investigator and clinic care provider. We’re grateful she’s here and are happy…
This study is for adults diagnosed with Type 2 Diabetes and fatty liver disease caused by MASH, sometimes called “fatty liver.” It focuses on people with liver cirrhosis due to MASH and aims to test the safety and effectiveness of a once-weekly injection of an investigational medication as a potential treatment.
To take part in the study, participants should be:
CEO and Medical Director
Director of Clinical Research
Clinical Research Coordinator
Navigator/Study Start-up Manager
Clinical Research Coordinator
Clinical Research Coordinator